nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.128	0.178	CbGbCtD
Triazolam—CYP3A7—Ifosfamide—testicular cancer	0.128	0.178	CbGbCtD
Triazolam—CYP3A5—Ifosfamide—testicular cancer	0.0959	0.134	CbGbCtD
Triazolam—CYP2C8—Ifosfamide—testicular cancer	0.0922	0.129	CbGbCtD
Triazolam—CYP2C9—Ifosfamide—testicular cancer	0.0643	0.0898	CbGbCtD
Triazolam—CYP3A5—Etoposide—testicular cancer	0.0458	0.064	CbGbCtD
Triazolam—CYP2C8—Etoposide—testicular cancer	0.0441	0.0615	CbGbCtD
Triazolam—CYP3A4—Ifosfamide—testicular cancer	0.0374	0.0522	CbGbCtD
Triazolam—CYP2C9—Cisplatin—testicular cancer	0.0313	0.0437	CbGbCtD
Triazolam—CYP3A4—Vinblastine—testicular cancer	0.0198	0.0277	CbGbCtD
Triazolam—CYP3A4—Etoposide—testicular cancer	0.0179	0.0249	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—testicular cancer	0.0122	0.017	CbGbCtD
Triazolam—Visual disturbance—Methotrexate—testicular cancer	0.000815	0.00288	CcSEcCtD
Triazolam—Muscle spasms—Cisplatin—testicular cancer	0.000815	0.00288	CcSEcCtD
Triazolam—Confusional state—Ifosfamide—testicular cancer	0.000809	0.00286	CcSEcCtD
Triazolam—Hepatic failure—Epirubicin—testicular cancer	0.000805	0.00284	CcSEcCtD
Triazolam—Pain—Bleomycin—testicular cancer	0.000803	0.00284	CcSEcCtD
Triazolam—Oedema—Ifosfamide—testicular cancer	0.000803	0.00283	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—testicular cancer	0.0008	0.00282	CcSEcCtD
Triazolam—Asthenia—Vinblastine—testicular cancer	0.000798	0.00282	CcSEcCtD
Triazolam—Tremor—Cisplatin—testicular cancer	0.000794	0.0028	CcSEcCtD
Triazolam—Ill-defined disorder—Cisplatin—testicular cancer	0.000787	0.00278	CcSEcCtD
Triazolam—Hyperhidrosis—Ifosfamide—testicular cancer	0.000776	0.00274	CcSEcCtD
Triazolam—Feeling abnormal—Bleomycin—testicular cancer	0.000774	0.00273	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—testicular cancer	0.000773	0.00273	CcSEcCtD
Triazolam—Vomiting—Chlorambucil—testicular cancer	0.000772	0.00272	CcSEcCtD
Triazolam—Anorexia—Ifosfamide—testicular cancer	0.000765	0.0027	CcSEcCtD
Triazolam—Malaise—Cisplatin—testicular cancer	0.000765	0.0027	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—testicular cancer	0.000761	0.00269	CcSEcCtD
Triazolam—Diarrhoea—Vinblastine—testicular cancer	0.000761	0.00269	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—testicular cancer	0.000761	0.00269	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—testicular cancer	0.000755	0.00267	CcSEcCtD
Triazolam—Pain—Dactinomycin—testicular cancer	0.000749	0.00264	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—testicular cancer	0.000747	0.00264	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—testicular cancer	0.000744	0.00263	CcSEcCtD
Triazolam—Irritability—Methotrexate—testicular cancer	0.000737	0.0026	CcSEcCtD
Triazolam—Dizziness—Vinblastine—testicular cancer	0.000735	0.0026	CcSEcCtD
Triazolam—Mood swings—Methotrexate—testicular cancer	0.000732	0.00258	CcSEcCtD
Triazolam—Ataxia—Methotrexate—testicular cancer	0.000726	0.00256	CcSEcCtD
Triazolam—Osteoarthritis—Epirubicin—testicular cancer	0.000723	0.00255	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—testicular cancer	0.000722	0.00255	CcSEcCtD
Triazolam—Nausea—Chlorambucil—testicular cancer	0.000721	0.00254	CcSEcCtD
Triazolam—Paraesthesia—Ifosfamide—testicular cancer	0.000721	0.00254	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—testicular cancer	0.000721	0.00254	CcSEcCtD
Triazolam—Anxiety—Cisplatin—testicular cancer	0.000719	0.00254	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000716	0.00253	CcSEcCtD
Triazolam—Dyspnoea—Ifosfamide—testicular cancer	0.000716	0.00253	CcSEcCtD
Triazolam—Somnolence—Ifosfamide—testicular cancer	0.000714	0.00252	CcSEcCtD
Triazolam—Discomfort—Cisplatin—testicular cancer	0.000713	0.00252	CcSEcCtD
Triazolam—Affect lability—Epirubicin—testicular cancer	0.000712	0.00251	CcSEcCtD
Triazolam—Vomiting—Vinblastine—testicular cancer	0.000707	0.0025	CcSEcCtD
Triazolam—Malaise—Etoposide—testicular cancer	0.000701	0.00247	CcSEcCtD
Triazolam—Decreased appetite—Ifosfamide—testicular cancer	0.000698	0.00246	CcSEcCtD
Triazolam—Headache—Vinblastine—testicular cancer	0.000697	0.00246	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—testicular cancer	0.000692	0.00244	CcSEcCtD
Triazolam—Fatigue—Ifosfamide—testicular cancer	0.000692	0.00244	CcSEcCtD
Triazolam—Oedema—Cisplatin—testicular cancer	0.000692	0.00244	CcSEcCtD
Triazolam—Hypersensitivity—Bleomycin—testicular cancer	0.000692	0.00244	CcSEcCtD
Triazolam—Pain—Ifosfamide—testicular cancer	0.000686	0.00242	CcSEcCtD
Triazolam—Constipation—Ifosfamide—testicular cancer	0.000686	0.00242	CcSEcCtD
Triazolam—Mood swings—Epirubicin—testicular cancer	0.000685	0.00242	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—testicular cancer	0.000683	0.00241	CcSEcCtD
Triazolam—Ataxia—Epirubicin—testicular cancer	0.00068	0.0024	CcSEcCtD
Triazolam—Tachycardia—Cisplatin—testicular cancer	0.000675	0.00238	CcSEcCtD
Triazolam—Asthenia—Bleomycin—testicular cancer	0.000674	0.00238	CcSEcCtD
Triazolam—Hypertension—Etoposide—testicular cancer	0.000671	0.00237	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—testicular cancer	0.000669	0.00236	CcSEcCtD
Triazolam—Hyperhidrosis—Cisplatin—testicular cancer	0.000669	0.00236	CcSEcCtD
Triazolam—Pruritus—Bleomycin—testicular cancer	0.000664	0.00235	CcSEcCtD
Triazolam—Feeling abnormal—Ifosfamide—testicular cancer	0.000661	0.00234	CcSEcCtD
Triazolam—Chest pain—Etoposide—testicular cancer	0.000661	0.00233	CcSEcCtD
Triazolam—Nausea—Vinblastine—testicular cancer	0.000661	0.00233	CcSEcCtD
Triazolam—Anorexia—Cisplatin—testicular cancer	0.00066	0.00233	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—testicular cancer	0.000659	0.00232	CcSEcCtD
Triazolam—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000656	0.00232	CcSEcCtD
Triazolam—Discomfort—Etoposide—testicular cancer	0.000653	0.00231	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—testicular cancer	0.000645	0.00228	CcSEcCtD
Triazolam—Confusional state—Etoposide—testicular cancer	0.000639	0.00226	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—testicular cancer	0.000638	0.00225	CcSEcCtD
Triazolam—Abdominal pain—Ifosfamide—testicular cancer	0.000635	0.00224	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—testicular cancer	0.000634	0.00224	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—testicular cancer	0.000629	0.00222	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—testicular cancer	0.000628	0.00222	CcSEcCtD
Triazolam—Dysuria—Methotrexate—testicular cancer	0.000624	0.0022	CcSEcCtD
Triazolam—Paraesthesia—Cisplatin—testicular cancer	0.000621	0.00219	CcSEcCtD
Triazolam—Tachycardia—Etoposide—testicular cancer	0.000619	0.00218	CcSEcCtD
Triazolam—Dyspnoea—Cisplatin—testicular cancer	0.000617	0.00218	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—testicular cancer	0.000613	0.00216	CcSEcCtD
Triazolam—Anorexia—Etoposide—testicular cancer	0.000604	0.00213	CcSEcCtD
Triazolam—Decreased appetite—Cisplatin—testicular cancer	0.000602	0.00212	CcSEcCtD
Triazolam—Diarrhoea—Dactinomycin—testicular cancer	0.000599	0.00212	CcSEcCtD
Triazolam—Vomiting—Bleomycin—testicular cancer	0.000597	0.00211	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—testicular cancer	0.000595	0.0021	CcSEcCtD
Triazolam—Pain—Cisplatin—testicular cancer	0.000592	0.00209	CcSEcCtD
Triazolam—Dermatitis—Bleomycin—testicular cancer	0.000592	0.00209	CcSEcCtD
Triazolam—Hypersensitivity—Ifosfamide—testicular cancer	0.000591	0.00209	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—testicular cancer	0.00059	0.00208	CcSEcCtD
Triazolam—Dysuria—Epirubicin—testicular cancer	0.000584	0.00206	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—testicular cancer	0.00058	0.00205	CcSEcCtD
Triazolam—Asthenia—Ifosfamide—testicular cancer	0.000576	0.00203	CcSEcCtD
Triazolam—Feeling abnormal—Cisplatin—testicular cancer	0.00057	0.00201	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—testicular cancer	0.000569	0.00201	CcSEcCtD
Triazolam—Pruritus—Ifosfamide—testicular cancer	0.000568	0.002	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—testicular cancer	0.000565	0.002	CcSEcCtD
Triazolam—Somnolence—Etoposide—testicular cancer	0.000564	0.00199	CcSEcCtD
Triazolam—Nausea—Bleomycin—testicular cancer	0.000558	0.00197	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—testicular cancer	0.000557	0.00197	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—testicular cancer	0.000557	0.00197	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—testicular cancer	0.000551	0.00195	CcSEcCtD
Triazolam—Diarrhoea—Ifosfamide—testicular cancer	0.000549	0.00194	CcSEcCtD
Triazolam—Fatigue—Etoposide—testicular cancer	0.000547	0.00193	CcSEcCtD
Triazolam—Jaundice—Epirubicin—testicular cancer	0.000543	0.00192	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—testicular cancer	0.000543	0.00192	CcSEcCtD
Triazolam—Pain—Etoposide—testicular cancer	0.000542	0.00191	CcSEcCtD
Triazolam—Constipation—Etoposide—testicular cancer	0.000542	0.00191	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—testicular cancer	0.000541	0.00191	CcSEcCtD
Triazolam—Dizziness—Ifosfamide—testicular cancer	0.000531	0.00187	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—testicular cancer	0.000522	0.00184	CcSEcCtD
Triazolam—Nausea—Dactinomycin—testicular cancer	0.00052	0.00184	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—testicular cancer	0.000518	0.00183	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—testicular cancer	0.000516	0.00182	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—testicular cancer	0.000515	0.00182	CcSEcCtD
Triazolam—Vomiting—Ifosfamide—testicular cancer	0.00051	0.0018	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—testicular cancer	0.00051	0.0018	CcSEcCtD
Triazolam—Dermatitis—Ifosfamide—testicular cancer	0.000506	0.00179	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—testicular cancer	0.000503	0.00177	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—testicular cancer	0.000503	0.00177	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—testicular cancer	0.000501	0.00177	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—testicular cancer	0.000498	0.00176	CcSEcCtD
Triazolam—Asthenia—Cisplatin—testicular cancer	0.000497	0.00175	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—testicular cancer	0.000482	0.0017	CcSEcCtD
Triazolam—Nausea—Ifosfamide—testicular cancer	0.000477	0.00168	CcSEcCtD
Triazolam—Diarrhoea—Cisplatin—testicular cancer	0.000473	0.00167	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—testicular cancer	0.000467	0.00165	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—testicular cancer	0.000466	0.00165	CcSEcCtD
Triazolam—Erythema—Methotrexate—testicular cancer	0.000465	0.00164	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—testicular cancer	0.000456	0.00161	CcSEcCtD
Triazolam—Asthenia—Etoposide—testicular cancer	0.000455	0.00161	CcSEcCtD
Triazolam—Pruritus—Etoposide—testicular cancer	0.000449	0.00158	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—testicular cancer	0.000446	0.00157	CcSEcCtD
Triazolam—Vomiting—Cisplatin—testicular cancer	0.00044	0.00155	CcSEcCtD
Triazolam—Dermatitis—Cisplatin—testicular cancer	0.000436	0.00154	CcSEcCtD
Triazolam—Erythema—Epirubicin—testicular cancer	0.000435	0.00154	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—testicular cancer	0.000434	0.00153	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—testicular cancer	0.000432	0.00152	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—testicular cancer	0.000432	0.00152	CcSEcCtD
Triazolam—Flatulence—Epirubicin—testicular cancer	0.000429	0.00151	CcSEcCtD
Triazolam—Tension—Epirubicin—testicular cancer	0.000427	0.00151	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—testicular cancer	0.000426	0.00151	CcSEcCtD
Triazolam—Nervousness—Epirubicin—testicular cancer	0.000423	0.00149	CcSEcCtD
Triazolam—Malaise—Methotrexate—testicular cancer	0.00042	0.00148	CcSEcCtD
Triazolam—Dizziness—Etoposide—testicular cancer	0.000419	0.00148	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—testicular cancer	0.000419	0.00148	CcSEcCtD
Triazolam—Nausea—Cisplatin—testicular cancer	0.000411	0.00145	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—testicular cancer	0.000404	0.00143	CcSEcCtD
Triazolam—Vomiting—Etoposide—testicular cancer	0.000403	0.00142	CcSEcCtD
Triazolam—Erythema—Doxorubicin—testicular cancer	0.000403	0.00142	CcSEcCtD
Triazolam—Agitation—Epirubicin—testicular cancer	0.0004	0.00141	CcSEcCtD
Triazolam—Dermatitis—Etoposide—testicular cancer	0.000399	0.00141	CcSEcCtD
Triazolam—Headache—Etoposide—testicular cancer	0.000397	0.0014	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—testicular cancer	0.000397	0.0014	CcSEcCtD
Triazolam—Chest pain—Methotrexate—testicular cancer	0.000396	0.0014	CcSEcCtD
Triazolam—Tension—Doxorubicin—testicular cancer	0.000395	0.0014	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—testicular cancer	0.000395	0.00139	CcSEcCtD
Triazolam—Malaise—Epirubicin—testicular cancer	0.000393	0.00139	CcSEcCtD
Triazolam—Discomfort—Methotrexate—testicular cancer	0.000391	0.00138	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—testicular cancer	0.000391	0.00138	CcSEcCtD
Triazolam—Syncope—Epirubicin—testicular cancer	0.00039	0.00138	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—testicular cancer	0.000387	0.00137	CcSEcCtD
Triazolam—Palpitations—Epirubicin—testicular cancer	0.000385	0.00136	CcSEcCtD
Triazolam—Confusional state—Methotrexate—testicular cancer	0.000383	0.00135	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—testicular cancer	0.000383	0.00135	CcSEcCtD
Triazolam—Nausea—Etoposide—testicular cancer	0.000377	0.00133	CcSEcCtD
Triazolam—Hypertension—Epirubicin—testicular cancer	0.000376	0.00133	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—testicular cancer	0.000374	0.00132	CcSEcCtD
Triazolam—Chest pain—Epirubicin—testicular cancer	0.000371	0.00131	CcSEcCtD
Triazolam—Agitation—Doxorubicin—testicular cancer	0.00037	0.00131	CcSEcCtD
Triazolam—Anxiety—Epirubicin—testicular cancer	0.000369	0.0013	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—testicular cancer	0.000367	0.0013	CcSEcCtD
Triazolam—Discomfort—Epirubicin—testicular cancer	0.000366	0.00129	CcSEcCtD
Triazolam—Malaise—Doxorubicin—testicular cancer	0.000363	0.00128	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—testicular cancer	0.000363	0.00128	CcSEcCtD
Triazolam—Anorexia—Methotrexate—testicular cancer	0.000362	0.00128	CcSEcCtD
Triazolam—Syncope—Doxorubicin—testicular cancer	0.000361	0.00128	CcSEcCtD
Triazolam—Confusional state—Epirubicin—testicular cancer	0.000358	0.00127	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—testicular cancer	0.000356	0.00126	CcSEcCtD
Triazolam—Oedema—Epirubicin—testicular cancer	0.000355	0.00125	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—testicular cancer	0.000354	0.00125	CcSEcCtD
Triazolam—Shock—Epirubicin—testicular cancer	0.00035	0.00123	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—testicular cancer	0.000348	0.00123	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—testicular cancer	0.000347	0.00122	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—testicular cancer	0.000344	0.00121	CcSEcCtD
Triazolam—Insomnia—Methotrexate—testicular cancer	0.000343	0.00121	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—testicular cancer	0.000343	0.00121	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—testicular cancer	0.000342	0.00121	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—testicular cancer	0.000341	0.0012	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—testicular cancer	0.000339	0.0012	CcSEcCtD
Triazolam—Anorexia—Epirubicin—testicular cancer	0.000339	0.0012	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—testicular cancer	0.000339	0.0012	CcSEcCtD
Triazolam—Somnolence—Methotrexate—testicular cancer	0.000338	0.00119	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—testicular cancer	0.000335	0.00118	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—testicular cancer	0.000332	0.00117	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—testicular cancer	0.00033	0.00117	CcSEcCtD
Triazolam—Oedema—Doxorubicin—testicular cancer	0.000329	0.00116	CcSEcCtD
Triazolam—Fatigue—Methotrexate—testicular cancer	0.000327	0.00116	CcSEcCtD
Triazolam—Pain—Methotrexate—testicular cancer	0.000325	0.00115	CcSEcCtD
Triazolam—Shock—Doxorubicin—testicular cancer	0.000324	0.00114	CcSEcCtD
Triazolam—Insomnia—Epirubicin—testicular cancer	0.000321	0.00113	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—testicular cancer	0.000321	0.00113	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—testicular cancer	0.000319	0.00113	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—testicular cancer	0.000318	0.00112	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—testicular cancer	0.000317	0.00112	CcSEcCtD
Triazolam—Somnolence—Epirubicin—testicular cancer	0.000316	0.00112	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—testicular cancer	0.000313	0.00111	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—testicular cancer	0.000313	0.0011	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—testicular cancer	0.000311	0.0011	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—testicular cancer	0.000309	0.00109	CcSEcCtD
Triazolam—Fatigue—Epirubicin—testicular cancer	0.000306	0.00108	CcSEcCtD
Triazolam—Pain—Epirubicin—testicular cancer	0.000304	0.00107	CcSEcCtD
Triazolam—Constipation—Epirubicin—testicular cancer	0.000304	0.00107	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—testicular cancer	0.0003	0.00106	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—testicular cancer	0.000297	0.00105	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—testicular cancer	0.000295	0.00104	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—testicular cancer	0.000293	0.00103	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—testicular cancer	0.000293	0.00103	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—testicular cancer	0.000292	0.00103	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—testicular cancer	0.000291	0.00103	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—testicular cancer	0.000286	0.00101	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—testicular cancer	0.000283	0.001	CcSEcCtD
Triazolam—Pain—Doxorubicin—testicular cancer	0.000281	0.000993	CcSEcCtD
Triazolam—Constipation—Doxorubicin—testicular cancer	0.000281	0.000993	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—testicular cancer	0.000281	0.000992	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—testicular cancer	0.00028	0.000988	CcSEcCtD
Triazolam—Asthenia—Methotrexate—testicular cancer	0.000272	0.000962	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—testicular cancer	0.000271	0.000957	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000269	0.000949	CcSEcCtD
Triazolam—Pruritus—Methotrexate—testicular cancer	0.000269	0.000948	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—testicular cancer	0.000262	0.000924	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—testicular cancer	0.00026	0.000918	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—testicular cancer	0.00026	0.000917	CcSEcCtD
Triazolam—Asthenia—Epirubicin—testicular cancer	0.000255	0.0009	CcSEcCtD
Triazolam—Pruritus—Epirubicin—testicular cancer	0.000251	0.000888	CcSEcCtD
Triazolam—Dizziness—Methotrexate—testicular cancer	0.000251	0.000887	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—testicular cancer	0.000243	0.000858	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—testicular cancer	0.000242	0.000855	CcSEcCtD
Triazolam—Vomiting—Methotrexate—testicular cancer	0.000241	0.000852	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—testicular cancer	0.000239	0.000844	CcSEcCtD
Triazolam—Headache—Methotrexate—testicular cancer	0.000238	0.00084	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—testicular cancer	0.000236	0.000833	CcSEcCtD
Triazolam—Dizziness—Epirubicin—testicular cancer	0.000235	0.00083	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—testicular cancer	0.000233	0.000821	CcSEcCtD
Triazolam—Vomiting—Epirubicin—testicular cancer	0.000226	0.000798	CcSEcCtD
Triazolam—Nausea—Methotrexate—testicular cancer	0.000226	0.000796	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—testicular cancer	0.000225	0.000794	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—testicular cancer	0.000224	0.00079	CcSEcCtD
Triazolam—Headache—Epirubicin—testicular cancer	0.000223	0.000786	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—testicular cancer	0.000217	0.000768	CcSEcCtD
Triazolam—Nausea—Epirubicin—testicular cancer	0.000211	0.000745	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—testicular cancer	0.000209	0.000738	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—testicular cancer	0.000207	0.000731	CcSEcCtD
Triazolam—Headache—Doxorubicin—testicular cancer	0.000206	0.000727	CcSEcCtD
Triazolam—Nausea—Doxorubicin—testicular cancer	0.000195	0.00069	CcSEcCtD
